Across TCGA pan-cancer cohorts, KRTAP19-5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of KRTAP19-5’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where KRTAP19-5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP19-5 is over-expressed in tumor.

HNSC, BRCA, and LIHC are the cancer types where KRTAP19-5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRTAP19-5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.178	.009	4	view →
BRCA	All	All	+0.012	.027	4	view →
LIHC	All	All	+0.089	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: KRTAP19-5 RNA expression & survival · all KRTAP19-5 data types